Kantonsspital St.Gallen
login

Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Ariella B Hanker, Joan T Garrett, Mónica Valeria Estrada, Preston D Moore, Paula González Ericsson, James P Koch, Emma Langley, Sharat Singh, Phillip S Kim, Garrett M Frampton, Eric Sanford, Philip Owens, Jennifer Becker, M Reid Groseclose, Stephen Castellino, Heikki Joensuu, Jens Huober, Jan C Brase, Samira Majjaj, Sylvain Brohée, David Venet, David Brown, José Baselga, Martine Piccart, Christos Sotiriou & Carlos L Arteaga

citation Hanker A B, Garrett J T, Estrada M V, Moore P D, Ericsson P G, Koch J P, Langley E, Singh S, Kim P S, Frampton G M, Sanford E, Owens P, Becker J, Groseclose M R, Castellino S, Joensuu H, Huober J, Brase J C, Majjaj S, Brohée S, Venet D, Brown D, Baselga J, Piccart M, Sotiriou C, Arteaga C L. Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2. Clin Cancer Res 2019; 25:1434.
   
type journal paper/review (English)
date of publishing 15-2-2019
journal title Clin Cancer Res (25/4)
ISSN electronic 1557-3265
pages 1434
PubMed 30770493
DOI 10.1158/1078-0432.CCR-18-4267